These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6242795)

  • 21. The short-term effect of nicotinic acid on intermediary metabolism in insulin-dependent diabetes mellitus.
    Hale PJ; Nattrass M
    Ann Clin Biochem; 1991 Jan; 28 ( Pt 1)():39-43. PubMed ID: 2024932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
    Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patients.
    Jimenez JT; Walford S; Home PD; Hanning I; Alberti KG
    Diabetologia; 1985 Oct; 28(10):728-33. PubMed ID: 3905470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion. A controlled study.
    Hermansen K; Møller A; Christensen CK; Christiansen JS; Schmitz O; Orskov H; Alberti KG; Mogensen CE
    Acta Endocrinol (Copenh); 1987 Mar; 114(3):433-9. PubMed ID: 3551432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolic response to insulin deprivation in idiopathic brittle diabetes.
    Husband DJ; Pernet A; Gill GV; Hanning I; Alberti KG
    Diabetes Res; 1986 May; 3(4):193-8. PubMed ID: 3527516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion.
    Hedman CA; Frystyk J; Lindström T; Oskarsson P; Arnqvist HJ
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):58-62. PubMed ID: 23865977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous intraperitoneal insulin infusion in patients with 'brittle' diabetes: favourable effects on glycaemic control and hospital stay.
    DeVries JH; Eskes SA; Snoek FJ; Pouwer F; Van Ballegooie E; Spijker AJ; Kostense PJ; Seubert M; Heine RJ
    Diabet Med; 2002 Jun; 19(6):496-501. PubMed ID: 12060062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of severe brittle diabetes with "Infusaid" implantable pumps.
    Gill GV; Husband DJ; Wright PD; Sharpe G; Taylor R; Walford S; Marshall SM; Alberti KG
    Diabetes Res; 1986 Mar; 3(3):135-7. PubMed ID: 3709039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overnight metabolic control with pulsed intermittent versus continuous subcutaneous insulin infusion.
    Levy-Marchal C; Albisser AM; Zinman B
    Diabetes Care; 1983; 6(4):356-60. PubMed ID: 6352209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic effects of physical exercise in insulin-dependent diabetics controlled by continuous subcutaneous insulin infusion or conventional injection therapy.
    Viberti GC; Home PD; Bilous RW; Alberti KG; Dalton N; Keen H; Pickup JC
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):515-20. PubMed ID: 6372348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of optimal glycaemic control with continuous subcutaneous insulin infusion on energy expenditure in type I diabetes mellitus.
    Leslie P; Jung RT; Isles TE; Baty J; Newton RW; Illingworth P
    Br Med J (Clin Res Ed); 1986 Nov; 293(6555):1121-6. PubMed ID: 3094802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemia.
    van Dijk PR; Logtenberg SJ; Gans RO; Bilo HJ; Kleefstra N
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):488-97. PubMed ID: 25041605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diurnal variation in carbohydrate tolerance to mixed meal in insulin-dependent diabetic adolescents during continuous intravenous insulin infusion (CIVII).
    Rewers M; Dmochowski K; Walczak M
    Endokrynol Pol; 1985; 36(1):1-7. PubMed ID: 4042995
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment with insulin analog lispro in IDDM with delayed absorption of subcutaneously applied human regular insulin and complicated intraperitoneal insulin infusion. A case report.
    Meier M; Brand J; Standl E; Schnell O
    Diabetes Care; 1998 Jul; 21(7):1044-5. PubMed ID: 9653592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Optimized Percutaneous Access System for CIPII.
    Garcia-Verdugo R; Erbach M; Schnell O
    J Diabetes Sci Technol; 2017 Jul; 11(4):814-821. PubMed ID: 28654300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of adult inpatients treated with continuous subcutaneous insulin infusion for diabetes mellitus: a systematic review.
    Anstey J; Yassaee A; Solomon A
    Diabet Med; 2015 Oct; 32(10):1279-88. PubMed ID: 25763540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic rhythms in adolescents with diabetes during treatment with porcine or human insulin.
    Hocking MD; Crase J; Rayner PH; Nattrass M
    Arch Dis Child; 1986 Apr; 61(4):341-5. PubMed ID: 3518640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of insulin deprivation and replacement on in vivo subcutaneous adipose tissue substrate metabolism in humans.
    Hagström-Toft E; Arner P; Näslund B; Ungerstedt U; Bolinder J
    Diabetes; 1991 Jun; 40(6):666-72. PubMed ID: 2040382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.